The global human insulin drugs and delivery devices market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by factors such as increasing prevalence of diabetes, rising awareness about diabetes among people, and increasing number of patients with type 2 diabetes mellitus. Insulin pumps are the fastest growing segment in the global human insulin drugs and delivery devices market due to their ability to provide continuous basal insulin infusion for 24 hours or more without any external intervention from the patient or healthcare provider. Insulin pens are also gaining traction in this market due to their ease-of-use and convenience for patients who need a quick dose of insulin before eating or after exercise. Insulin syringes are also gaining traction in this market due to their low cost per unit dose compared with other types of delivery devices such as pens and pumps which require disposable cartridges that need frequent replacement.
Some Of The Growth Factors Of This Market:
- Insulin drugs are used for treatment of diabetes mellitus type 1 and type 2, which are chronic diseases that affect millions worldwide and have been on the rise in recent years due to unhealthy lifestyles and diets that lead to obesity and other lifestyle-related diseases such as cardiovascular disease, stroke, cancer etc, which has led to an increase in demand for insulin drugs globally.
- Insulin delivery devices are also witnessing significant growth due to their ability to provide accurate dosing with minimal side effects as compared with injections or infusions.
Industry Growth Insights published a new data on “Human Insulin Drugs And Delivery Devices Market”. The research report is titled “Human Insulin Drugs And Delivery Devices Market research by Types (Insulin Pumps, Insulin Pens, Insulin Syringes, Basal or Long Acting Insulins, Bolus or Fast-Acting Insulins), By Applications (Hospital, Household), By Players/Companies Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Medtronic, Insulet, Ypsomed, Becton Dickinson”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Insulin Drugs And Delivery Devices Market Research Report
By Type
Insulin Pumps, Insulin Pens, Insulin Syringes, Basal or Long Acting Insulins, Bolus or Fast-Acting Insulins
By Application
Hospital, Household
By Companies
Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Medtronic, Insulet, Ypsomed, Becton Dickinson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Human Insulin Drugs And Delivery Devices Market Report Segments:
The global Human Insulin Drugs And Delivery Devices market is segmented on the basis of:
Types
Insulin Pumps, Insulin Pens, Insulin Syringes, Basal or Long Acting Insulins, Bolus or Fast-Acting Insulins
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Household
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk
- Sanofi Aventis
- Eli Lilly
- Biocon
- Julphar
- Exir
- Medtronic
- Insulet
- Ypsomed
- Becton Dickinson
Highlights of The Human Insulin Drugs And Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Insulin Pumps
- Insulin Pens
- Insulin Syringes
- Basal or Long Acting Insulins
- Bolus or Fast-Acting Insulins
- By Application:
- Hospital
- Household
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Insulin Drugs And Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human insulin drugs and delivery devices are medications that help people with diabetes manage their blood sugar levels. These medications work by helping the body to use insulin more effectively. Human insulin drugs can come in pill, injection, or infusion form. Delivery devices include pumps, pens, and meters that help people monitor their blood sugar levels and administer their medication as needed.
Some of the major players in the human insulin drugs and delivery devices market are Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Medtronic, Insulet, Ypsomed, Becton Dickinson.
The human insulin drugs and delivery devices market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Human Insulin Drugs And Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Human Insulin Drugs And Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Human Insulin Drugs And Delivery Devices Market - Supply Chain
4.5. Global Human Insulin Drugs And Delivery Devices Market Forecast
4.5.1. Human Insulin Drugs And Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Human Insulin Drugs And Delivery Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Human Insulin Drugs And Delivery Devices Market Absolute $ Opportunity
5. Global Human Insulin Drugs And Delivery Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Type
5.3.1. Insulin Pumps
5.3.2. Insulin Pens
5.3.3. Insulin Syringes
5.3.4. Basal or Long Acting Insulins
5.3.5. Bolus or Fast-Acting Insulins
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Human Insulin Drugs And Delivery Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Household
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Human Insulin Drugs And Delivery Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Human Insulin Drugs And Delivery Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Human Insulin Drugs And Delivery Devices Demand Share Forecast, 2019-2026
9. North America Human Insulin Drugs And Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Household
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Type
9.7.1. Insulin Pumps
9.7.2. Insulin Pens
9.7.3. Insulin Syringes
9.7.4. Basal or Long Acting Insulins
9.7.5. Bolus or Fast-Acting Insulins
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Human Insulin Drugs And Delivery Devices Demand Share Forecast, 2019-2026
10. Latin America Human Insulin Drugs And Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Household
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Type
10.7.1. Insulin Pumps
10.7.2. Insulin Pens
10.7.3. Insulin Syringes
10.7.4. Basal or Long Acting Insulins
10.7.5. Bolus or Fast-Acting Insulins
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Human Insulin Drugs And Delivery Devices Demand Share Forecast, 2019-2026
11. Europe Human Insulin Drugs And Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Household
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Type
11.7.1. InsulinPumps
11.7.2. Insulin Pens
11.7.3. Insulin Syringes
11.7.4. Basal or Long Acting Insulins
11.7.5. Bolus or Fast-Acting Insulins
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Human Insulin Drugs And Delivery Devices Demand Share, 2019-2026
12. Asia Pacific Human Insulin Drugs And Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Household
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Type
12.7.1. Insulin Pumps
12.7.2. Insulin Pens
12.7.3. Insulin Syringes
12.7.4. Basal or Long Acting Insulins
12.7.5. Bolus or Fast-Acting Insulins
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Human Insulin Drugs And Delivery Devices Demand Share, 2019-2026
13. Middle East & Africa Human Insulin Drugs And Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Household
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Human Insulin Drugs And Delivery Devices Market Size and Volume Forecast by Type
13.7.1. Insulin Pumps
13.7.2. Insulin Pens
13.7.3. Insulin Syringes
13.7.4. Basal or Long Acting Insulins
13.7.5. Bolus or Fast-Acting Insulins
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Human Insulin Drugs And Delivery Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Human Insulin Drugs And Delivery Devices Market: Market Share Analysis
14.2. Human Insulin Drugs And Delivery Devices Distributors and Customers
14.3. Human Insulin Drugs And Delivery Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novo Nordisk
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi Aventis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eli Lilly
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biocon
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Julphar
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Exir
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Medtronic
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Insulet
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ypsomed
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Becton Dickinson
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook